Search results
Showing 1 to 12 of 12 results for retinitis pigmentosa
Insertion of a subretinal prosthesis system for retinitis pigmentosa (HTG392)
Evidence-based recommendations on insertion of a subretinal prosthesis system for retinitis pigmentosa. This involves performing a vitrectomy and implanting a microchip underneath the macula using a transscleral, then subretinal approach.
Insertion of an epiretinal prosthesis for retinitis pigmentosa (HTG372)
Evidence-based recommendations on insertion of an epiretinal prosthesis for retinitis pigmentosa. This involves inserting an implant into the eye that receives data from a small camera on the person's glasses and then stimulates healthy cells in the retina to see basic images.
encourages further research on insertion of an epiretinal prosthesis for retinitis pigmentosa. Outcomes should include the impact on...
NICE encourages further research on subretinal prosthesis system for retinitis pigmentosa. Outcomes should include the impact on quality...
Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies in people with vision loss caused by inherited retinal dystrophy from confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.
OCU400 for treating retinitis pigmentosa in people 5 years and over [PDID6687]
Awaiting development Reference number: GID-TA11905 Expected publication date: TBC
Awaiting development Reference number: GID-TA11332 Expected publication date: TBC
Summary of the evidence on avanafil for treating erectile dysfunction to inform local NHS planning and decision-making
Insertion of an epiretinal prosthesis for retinitis pigmentosa (IPG519)
We have moved interventional procedures guidance 519 to become HealthTech guidance 372. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Insertion of a subretinal prosthesis system for retinitis pigmentosa (IPG537)
We have moved interventional procedures guidance 537 to become HealthTech guidance 392. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.